Research index
Thyroid
Brierley, Goldstein, Krzyzanowska
TNM Online26 Feb 2017
NobleIDark:/48914/w1/20260525/C0ABAE1BDOI10.1002/9780471420194.tnmm48
Thyroid
Brierley, Goldstein, Krzyzanowska · TNM Online · 2017 · Subscription
NobleIDark:/48914/w1/20260525/C0ABAE1BDOI10.1002/9780471420194.tnmm48
The full text is at the publisher
You can read the abstract here, or open it at the publisher.
Abstract
Summary Thyroid cancer can develop from follicular cells of the thyroid, including papillary and follicular (differentiated thyroid cancer), insular and anaplastic thyroid cancers, and those derived from C cells of the thyroid, the medullary thyroid cancers. The usual presentation and work‐up will be discussed. The initial treatment for all thyroid malignancies (lymphoma excepted) is surgery. The controversies with regard to the extent of surgery and central node dissection will be reviewed, as will the role of radioactive iodine in low‐ and intermediate‐risk differentiated thyroid cancer. Although limited, there is a role for external beam radiotherapy in locally‐advanced thyroid cancer, especially anaplastic, and indications will be given. The role of chemotherapy is limited, but there is increasing evidence of activity of targeted agents.